These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21138684)

  • 1. [The expressions of STAT3, WWOX and c-myc in human non small cell lung cancer tissue and correlativity analysis].
    Hu FY; Wang LP; Hou LL; Yin G; Wang HC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1203-5, 1209. PubMed ID: 21138684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
    Donati V; Fontanini G; Dell'Omodarme M; Prati MC; Nuti S; Lucchi M; Mussi A; Fabbri M; Basolo F; Croce CM; Aqeilan RI
    Clin Cancer Res; 2007 Feb; 13(3):884-91. PubMed ID: 17289881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of APC and c-Myc and its implication on non-small cell lung cancer].
    Wang SF; Liu Q; Zhang SF; Liao DY; Xu H; Zhang WY; Li WM; Liu LX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):822-6. PubMed ID: 21302450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc.
    Li HS; Lv RQ; Liu L
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):135-141. PubMed ID: 29364480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
    Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
    Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
    Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and clinical characterization of the putative tumor suppressor WWOX in non-small cell lung cancer.
    Becker S; Markova B; Wiewrodt R; Hoffarth S; Hähnel PS; Pleiner S; Schmidt LH; Breitenbuecher F; Schuler M
    J Thorac Oncol; 2011 Dec; 6(12):1976-83. PubMed ID: 21892104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
    Wang L; Kong W; Liu B; Zhang X
    Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms.
    Lee HJ; Seol HS; Kim JY; Chun SM; Suh YA; Park YS; Kim SW; Choi CM; Park SI; Kim DK; Kim YH; Jang SJ
    Ann Surg Oncol; 2013 Jan; 20(1):200-8. PubMed ID: 22915320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of pSTAT3 in non-small cell lung cancer and its clinical significance].
    Wang RJ; Zhang JZ; Wang P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):288-90. PubMed ID: 22394639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
    Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
    Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
    Bleau AM; Freire J; Pajares MJ; Zudaire I; Anton I; Nistal-Villán E; Redrado M; Zandueta CN; Garmendia I; Ajona D; Blanco D; Pio R; Lecanda F; Calvo A; Montuenga LM
    Int J Cancer; 2014 Dec; 135(11):2516-27. PubMed ID: 24473991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
    Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer.
    Zhang E; Li W; Yin D; De W; Zhu L; Sun S; Han L
    Tumour Biol; 2016 Mar; 37(3):4007-15. PubMed ID: 26482621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
    Lin M; Bi H; Yan Y; Huang W; Zhang G; Zhang G; Tang S; Liu Y; Zhang L; Ma J; Zhang J
    Oncotarget; 2017 Apr; 8(14):23436-23447. PubMed ID: 28423582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.